303 related articles for article (PubMed ID: 24150707)
41. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.
Liu R; Wang T; Zhang B; Qin L; Wu C; Li Q; Ma L
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):252-8. PubMed ID: 25515572
[TBL] [Abstract][Full Text] [Related]
42. Effects of formulation on the bioavailability of lutein and zeaxanthin: a randomized, double-blind, cross-over, comparative, single-dose study in healthy subjects.
Evans M; Beck M; Elliott J; Etheve S; Roberts R; Schalch W
Eur J Nutr; 2013 Jun; 52(4):1381-91. PubMed ID: 23052623
[TBL] [Abstract][Full Text] [Related]
43. Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract.
Berendschot TT; Broekmans WM; Klöpping-Ketelaars IA; Kardinaal AF; Van Poppel G; Van Norren D
Arch Ophthalmol; 2002 Dec; 120(12):1732-7. PubMed ID: 12470150
[TBL] [Abstract][Full Text] [Related]
44. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.
; SanGiovanni JP; Chew EY; Clemons TE; Ferris FL; Gensler G; Lindblad AS; Milton RC; Seddon JM; Sperduto RD
Arch Ophthalmol; 2007 Sep; 125(9):1225-32. PubMed ID: 17846363
[TBL] [Abstract][Full Text] [Related]
45. A possible role for lutein and zeaxanthin in cognitive function in the elderly.
Johnson EJ
Am J Clin Nutr; 2012 Nov; 96(5):1161S-5S. PubMed ID: 23053547
[TBL] [Abstract][Full Text] [Related]
46. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
[TBL] [Abstract][Full Text] [Related]
47. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
48. Association between dietary carbohydrate intake and dietary glycemic index and risk of age-related cataract: a meta-analysis.
Wu H; Zhang H; Li P; Gao T; Lin J; Yang J; Wu Y; Ye J
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3660-8. PubMed ID: 24833741
[TBL] [Abstract][Full Text] [Related]
49. Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates.
Vishwanathan R; Neuringer M; Snodderly DM; Schalch W; Johnson EJ
Nutr Neurosci; 2013 Jan; 16(1):21-9. PubMed ID: 22780947
[TBL] [Abstract][Full Text] [Related]
50. Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging.
Tanito M; Obana A; Gohto Y; Okazaki S; Gellermann W; Ohira A
Jpn J Ophthalmol; 2012 Sep; 56(5):488-96. PubMed ID: 22699751
[TBL] [Abstract][Full Text] [Related]
51. Dietary Lutein Plus Zeaxanthin Intake and DICER1 rs3742330 A > G Polymorphism Relative to Colorectal Cancer Risk.
Kim J; Lee J; Oh JH; Chang HJ; Sohn DK; Kwon O; Shin A; Kim J
Sci Rep; 2019 Mar; 9(1):3406. PubMed ID: 30833603
[TBL] [Abstract][Full Text] [Related]
52. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
[TBL] [Abstract][Full Text] [Related]
53. The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.
Khachik F; de Moura FF; Chew EY; Douglass LW; Ferris FL; Kim J; Thompson DJ
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5234-42. PubMed ID: 17122108
[TBL] [Abstract][Full Text] [Related]
54. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
55. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
[TBL] [Abstract][Full Text] [Related]
56. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.
Eliassen AH; Hendrickson SJ; Brinton LA; Buring JE; Campos H; Dai Q; Dorgan JF; Franke AA; Gao YT; Goodman MT; Hallmans G; Helzlsouer KJ; Hoffman-Bolton J; Hultén K; Sesso HD; Sowell AL; Tamimi RM; Toniolo P; Wilkens LR; Winkvist A; Zeleniuch-Jacquotte A; Zheng W; Hankinson SE
J Natl Cancer Inst; 2012 Dec; 104(24):1905-16. PubMed ID: 23221879
[TBL] [Abstract][Full Text] [Related]
57. Body mass index and risk of age-related cataract: a meta-analysis of prospective cohort studies.
Ye J; Lou LX; He JJ; Xu YF
PLoS One; 2014; 9(2):e89923. PubMed ID: 24587127
[TBL] [Abstract][Full Text] [Related]
58. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Wang JJ; Flood V; Rochtchina E; Smith W; Mitchell P
Ophthalmology; 2008 Feb; 115(2):334-41. PubMed ID: 17664009
[TBL] [Abstract][Full Text] [Related]
59. Lutein and zeaxanthin dietary intake and age related macular degeneration.
Flood V; Rochtchina E; Wang JJ; Mitchell P; Smith W
Br J Ophthalmol; 2006 Jul; 90(7):927-8. PubMed ID: 16782963
[No Abstract] [Full Text] [Related]
60. Macular pigment and percentage of body fat.
Nolan J; O'Donovan O; Kavanagh H; Stack J; Harrison M; Muldoon A; Mellerio J; Beatty S
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3940-50. PubMed ID: 15505040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
